The pericardium plays an important role in optimizing cardiac motion and chamber pressures and serves as a barrier to pathology. In addition to pericardial anatomy and function, this review article covers a variety of pericardial conditions, with mention of potential pitfalls encountered during interpretation of diagnostic imaging. Normal and abnormal appearance of pericardium on CT and MR imaging is emphasized, including dynamic imaging correlates of pericardial pathophysiology. 1. Introduction More than just a tissue, the pericardium is an organ with specific functions and an embryologic origin distinct from the heart. Whereas the heart is derived from splanchnic mesoderm, the pericardium is derived from somatic mesoderm [1–3]. Long-recognized functions of the pericardium include anchoring the heart in the mediastinum, minimizing the friction of cardiac motion, and serving as a barrier from infection and neoplasm . More recently, the pericardium has been described as an intracardiac pressure modulator, limiting acute distention of any one cardiac chamber and preserving myofibril function by preventing sarcomere overlengthening [5, 6]. As with other organs, the pericardium is subject to various disease processes, include inflammatory, infectious, fibrotic, metabolic, and neoplastic. Imaging of these processes has advanced significantly in the past decade, with the refinement of multidetector CT and high-field-strength MRI. CT and MR permit visualization of the entire pericardium by virtue of three-dimensional acquisition and multiplanar imaging, respectively, and provide better assessment of surrounding structures than the prior standard of echocardiography . In addition, MR techniques allow the evaluation of pericardial function, particularly as it relates to the problem of differentiating myocardial restriction from pericardial constriction, the latter being surgically treatable . 2. Anatomic Considerations As with the other serosal surfaces of the body, the pericardium has parietal and visceral layers. The parietal layer of pericardium is several times thicker than the visceral pericardium . The normal combined pericardial thickness is 2？mm or less (Figures 1(a) and 1(b)). 2-3？mm is considered equivocal, whereas 4？mm thickness at any point is abnormal [9, 10]. The normal pericardial stabilizers include the great vessel reflections and several ligaments (pericardial-sternal, pericardial-vertebral, and pericardial-diaphragmatic) (Figure 1(c)) . Figure 1: Normal pericardium. (a) Gated contrast-enhanced axial CT and (b) axial double
S. J. Lavine, C. A. Campbell, R. A. Kloner, and S. J. Gunther, “Diastolic filling in acute left ventricular dysfunction: role of the pericardium,” Journal of the American College of Cardiology, vol. 12, no. 5, pp. 1326–1333, 1988.
S. I. Reynertson, S. N. Konstadt, E. K. Louie, L. Segil, T. L. K. Rao, and P. J. Scanlon, “Alterations in transesophageal pulsed Doppler indexes of filling of the left ventricle after pericardiotomy,” Journal of the American College of Cardiology, vol. 18, no. 7, pp. 1655–1660, 1991.
W. G. Hundley, D. A. Bluemke, J. P. Finn et al., “ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance,” Journal of the American College of Cardiology, vol. 55, no. 23, pp. 2614–2662, 2010.
M. T. Truong, J. J. Erasmus, G. W. Gladish et al., “Anatomy of pericardial recesses on multidetector CT: implications for oncologic imaging,” American Journal of Roentgenology, vol. 181, no. 4, pp. 1109–1113, 2003.
M. J. Budoff, B. Lu, S. Mao et al., “Evaluation of fluid collection in the pericardial sinuses and recesses: noncontrast-enhanced electron beam tomography,” Investigative Radiology, vol. 35, no. 6, pp. 359–365, 2000.
R. C. Hendel, M. R. Patel, C. M. Kramer et al., “ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging,” Journal of the American College of Cardiology, vol. 48, no. 7, pp. 1475–1497.
D. Verhaert, R. S. Gabrie, D. Johnston, B. W. Lytle, M. Y. Desai, and A. L. Klein, “The role of multimodality imaging in the management of pericardial disease,” Circulation, vol. 3, no. 3, pp. 333–343, 2010.
J. S. Sun, K. J. Park, and D. K. Kang, “CT findings in patients with pericardial effusion: differentiation of malignant and benign disease,” American Journal of Roentgenology, vol. 194, no. 6, pp. W489–W494, 2010.
M. Francone, S. Dymarkowski, M. Kalantzi, F. E. Rademakers, and J. Bogaert, “Assessment of ventricular coupling with real-time cine MRI and its value to differentiate constrictive pericarditis from restrictive cardiomyopathy,” European Radiology, vol. 16, no. 4, pp. 944–951, 2006.
M. Francone, S. Dymarkowski, M. Kalantzi, and J. Bogaert, “Real-time cine MRI of ventricular motion: a novel approach to assess ventricular coupling,” Journal of Magnetic Resonance Imaging, vol. 21, no. 3, pp. 305–309, 2005.
A. Kovanlikaya, L. P. Burke, M. D. Nelson, and J. Wood, “Characterizing chronic pericarditis using steady-state free-precession cine MR imaging,” American Journal of Roentgenology, vol. 179, no. 2, pp. 475–476, 2002.
C. Comoglio, F. Sansone, L. Delsedime, A. Campanella, F. Ceresa, and M. Rinaldi, “Mesothelial cyst of the pericardium, absent on earlier computed tomography,” Texas Heart Institute Journal, vol. 37, no. 3, pp. 354–357, 2010.
P. Prakash, M. K. Kalra, J. R. Stone, J.-A. O. Shepard, and S. R. Digumarthy, “Imaging findings of pericardial metastasis on chest computed tomography,” Journal of Computer Assisted Tomography, vol. 34, no. 4, pp. 554–558, 2010.
M. L. Grebenc, D. C. M. L. Rosado, A. P. Burke, C. E. Green, and J. R. Galvin, “Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation,” Radiographics, vol. 20, no. 4, pp. 1073–1103, 2000.
F. E. Johnson, M. K. Wolverson, M. Sundaram, and E. Heiberg, “Unsuspected malignant pericardial effusion causing cardiac tamponade: rapid diagnosis by computed tomography,” Chest, vol. 82, no. 4, pp. 501–503, 1982.
E. A. Maher, F. A. Shepherd, and D. J. R. Todd, “Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade,” Journal of Thoracic and Cardiovascular Surgery, vol. 112, no. 3, pp. 637–643, 1996.
T. Dosios, N. Theakos, D. Angouras, and P. Asimacopoulos, “Risk factors affecting the survival of patients with pericardial effusion submitted to subxiphoid pericardiostomy,” Chest, vol. 124, no. 1, pp. 242–246, 2003.